Paul Henriot
Overview
Explore the profile of Paul Henriot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Henriot P, El-Kassas M, Anwar W, Girgis S, El Gaafary M, Jean K, et al.
PLoS Comput Biol
. 2025 Feb;
21(2):e1012850.
PMID: 39993020
Mathematical models are powerful tools to analyze pathogen spread and assess control strategies in healthcare settings. Nevertheless, available models focus on nosocomial transmission through direct contact or aerosols rather than...
2.
Henriot P, Buelow E, Petit F, Ploy M, Dagot C, Opatowski L
Sci Total Environ
. 2024 Mar;
924:171643.
PMID: 38471588
The emergence and selection of antibiotic resistance is a major public health problem worldwide. The presence of antibiotic-resistant bacteria (ARBs) in natural and anthropogenic environments threatens the sustainability of efforts...
3.
Kovacevic A, Smith D, Rahbe E, Novelli S, Henriot P, Varon E, et al.
Elife
. 2024 Mar;
13.
PMID: 38451256
Non-pharmaceutical interventions implemented to block SARS-CoV-2 transmission in early 2020 led to global reductions in the incidence of invasive pneumococcal disease (IPD). By contrast, most European countries reported an increase...
4.
Henriot P, Anwar W, El Gaafary M, Abdo S, Rafik M, Hussein W, et al.
PLOS Glob Public Health
. 2024 Feb;
4(2):e0002821.
PMID: 38358962
When compliance with infection control recommendations is non-optimal, hospitals may play an important role in hepatitis C (HCV) transmission. However, few studies have analyzed the nosocomial HCV acquisition risk based...
5.
Smith D, Jijon S, Oodally A, Shirreff G, Ait Bouziad K, Ante-Testard P, et al.
Occup Environ Med
. 2023 Mar;
80(5):268-272.
PMID: 36914254
Objectives: To quantify the burden of COVID-19-related sick leave during the first pandemic wave in France, accounting for sick leaves due to symptomatic COVID-19 ('symptomatic sick leaves') and those due...
6.
Henriot P, Castry M, Luong Nguyen L, Shimakawa Y, Jean K, Temime L
Aliment Pharmacol Ther
. 2022 Jun;
56(4):558-569.
PMID: 35758763
Background: Healthcare settings, where invasive procedures are frequently performed, may play an important role in the transmission dynamics of blood-borne pathogens when compliance with infection control precautions is suboptimal. Aims:...